Positron emission tomography/computed tomography: A clinical tool for evaluation of enthesitis in patients with spondyloarthritides

Rheumatology

Volumn 49, Issue 2, 2010, Pages 348-354

  Taniguchi, Yoshinori ^a   Arii, Kaoru ^b   Kumon, Yoshitaka ^c   Fukumoto, Mitsutaka ^c   Ohnishi, Takenao ^c   Horino, Taro ^a   Kagawa, Toru ^a   Kobayashi, Shigeto ^d   Ogawa, Yasuhiro ^c   Terada, Yoshio ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b KOCHI RED CROSS HOSPITAL   (Japan)

^c KOCHI UNIVERSITY   (Japan)

^d Juntendo University Hospital   (Japan)

Author keywords

18F fluorodeoxyglucose PET CT; Enthesitis; Rheumatoid arthritis; Spondyloarthritides

Indexed keywords

CELECOXIB; FLUORODEOXYGLUCOSE F 18; GALLIUM; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENTHESITIS; FALSE POSITIVE RESULT; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SPONDYLOARTHROPATHY;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPONDYLARTHRITIS; TENDINOPATHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77950440624     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep379     Document Type: Article

References (26)

1. Nash P, Mease PJ, Braun J, van der Heijde D. Seronegative spondyloarthropathies: to lump or split? Ann Rheum Dis 2005;64(Suppl. II):9-13.
2. Takigawa T, Tanaka M, Nakanishi K et al. SAPHO syndrome associated spondylitis. Eur Spine J 2008;17: 1391-7.
3. Godfrin B, Zabraniecki L, Lamboley V et al. Spondyloarthropathy with entheseal pain. A prospective study in 33 patients. Joint Bone Spine 2004;71:557-62.
4. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379-90.
5. Caplanne D, Tubach F, Le Parc JM. Late onset spondylarthropathy: clinical and biological comparison with early onset patients. Ann Rheum Dis 1997;56:176-9.
6. El-Khoury GY, Kathol MH, Brandser EA. Seronegative spondyloarthropathies. Radiol Clin North Am 1996;34: 343-57.
7. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27: 235-8.
8. Kubota R, Kubota K, Yamada S et al. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nuc Med 1994;35:104-12.
9. Fukuzumi M, Shinomiya H, Shimizu Y et al. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via Glut1. Infect immune 1996;64: 108-12.
10. Kruger S, Buck AK, Mottaghy FM et al. Use of integrated FDG-PET/CT in sarcoidosis. Clin Imaging 2008;32: 269-73.
11. Beckers C, Ribbens C, Andre B et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 2004;45:956-64.
12. Szmodis ML, Reba RC, Earl-Graef D. Positron emission tomography in the diagnosis and management of giant cell arteritis. Headache 2007;47:1216-9.
13. Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 2007;48: 35-45.
14. Yun M, Kim W, Adam LE et al. F-18 FDG uptake in a patient with psoriatic arthritis: imaging correlation with patient symptoms. Clin Nucl Med 2001;26:692-3.
15. Wendling D, Blagosklonov O, Streit G et al. FDG PET/CT scan of inflammatory spondylodiscitis lesions in ankylos- ing spondylitis, and short term evolution during anti-tumor necrosis factor treatment. Ann Rheum Dis 2005;64: 1663-5.
16. Amor B, Dougadas M, Mijiyawa M. Criteria of the classification of spondylarthropathies (in French). Rev Rhum Mal Osteoartic 1990;57:85-9.
17. Diabetes Association American. Diagnosis and classifica- tion of diabetes mellitus. American Diabetes Association. Diabetes Care 2006;29(Suppl. 1):S43-8.
18. Yamamoto Y, Oguri H, Yamada R et al. Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography. Int J Gynaecol Obstet 2008;102:124-7.
19. Yamaguchi A, Tsuchiya N, Mitsui H et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum 1995;38: 1672-7.
20. Wiell C, Szkudlarek M, Hasselquist M et al. Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther 2007;9: R119.
21. Braun J, Baraliakos X, Golder W et al. Magnetic resonance imaging examinations of the spine in patients with anky-losing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003;48:1126-36.
22. Baraliakos X, Davis J, Tsuji W, Braun J. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor a receptor fusion protein etanercept. Arthritis Rheum 2005;52:1216-23.
23. Althoff CE, Appel H, Rudwaleit M et al. Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis. Ann Rheum Dis 2007;66:983-5.
24. Sieper J, Appel H, Braun J, Rudwaleit M. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 2008;58:649-56.
25. van der Heijde D, Landewe R, Einstein S et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 2008;58:1324-31.
26. Sieper J. Developments in the scientific and clinical understanding of the spondyloarthritides. Arthritis Res Ther 2009;11:208.